Skip navigation

Improving Anticoagulation Therapy Services

Tuesday 15 March 2016
Hallam Conference Centre, London

Improving Anticoagulation Therapy Services

This event has now past, but there may well be news on the event including presentations and quotes from the day at our News pages here, a full list of our forthcoming events is available here.

Follow the conference on twitter #Anticoagulation

The conference will open focusing on the patient and on self monitoring and empowering patients following recommendation from NICE on self monitoring which stated that “The evidence shows that greater use of self-monitoring offers clinical and patient benefit and, over time, is likely to result in reductions in heart attacks and strokes caused by blood clots…People on long-term anticoagulation need to monitor their blood regularly to make sure they are taking the right dose of their drug. Because self-monitoring provides almost instant results, self-monitoring can reduce anxiety, provide a sense of control for the patient and remove the need to frequently attend clinics or hospitals. The Committee also heard that self-monitoring allows people to visit, or act as a carer for, other family members, without having to worry about attending testing appointments.” Professor Carole Longson, NICE Health Technology Evaluation Centre Director

The conference will continue with an update on monitoring adherence to the revised AF guidelines, and more recently the Atrial fibrillation: treatment and management Quality Standard which was published on the 9th July 2015 by NICE.  NICE has recommended that anticoagulants should be offered instead of aspirin for stroke prevention. NICE stated that offering patients anticoagulants could help prevent thousands of strokes and premature deaths from atrial fibrillation (AF), according to NICE. Around 800,000 people in England are known to be at risk of stroke from AF. Of these, half are taking anticoagulants, and a third are currently taking aspirin. However, two-thirds of people admitted to a hospital with a stroke caused by AF are not taking recommended anticoagulants. NICE estimates that with effective detection and protection with anticoagulant drugs, 7,000 strokes and 2,000 premature deaths could be avoided each year. The session will look out how you can improve effective detection and management of these patients in your service. Dr Matthew Fay, a GP and specialist member of the committee that developed the standard, said: “The ineffectiveness of aspirin and the need to remove it from the AF patient pathway receives a much needed, and rare, negative statement. This should provide the impetus to those who still speculate on the value of aspirin from historic practice to have the discussion with their patients about the benefits of anticoagulation hopefully before, and not after a devastating stroke event.” NICE July 2015

100% of the delegates at our last anticoagulation therapy conference would recommend this conference.

Also of interest:

Non-Medical Prescribing for Pain
Wednesday 3 February 
Thestudio Conference Centre
AF AssociationAssociation for PrescribersGood Governance InstituteHayward AnticoagulationSociety of Vascular NursesUK Pharmacogenetics & Stratified Medicine Network
GGI (Good Governance Institute) accredited conferences CPD Member ASGBI (Association of Surgeons of Great Britain and Ireland) professional partner BADS (British Association of Day Surgery) accredited conferences